ARCHIVES

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Brain Gliomas Progress When Gene Function Is Lost

April 25, 2003

New Compounds To Treat Gleevec-Resistant CML

January 26, 2007

NCAB Approves Fallout Study On Split Vote

March 13, 1981

DeVita Denies NCI Broke Faith With Communities On CHOP Awards, Says Total Of 30 “Not Absolute”

August 15, 1980

RFA For Patterns Of Care Studies Announced By DCCR

November 10, 1978

Majority Of U.S. Cancer Patients Receive High-Quality Care, ASCO Study Finds

July 29, 2005